Mitologics SAS is an innovative biotechnology company (SME) specialized in the detection of mitochondrial alterations for applications in toxicology and pharmacology. The team has a strong expertise in cell and mitochondrial biology, metabolism, apoptosis and cancer. Mitologics owns three in vitro screening platforms on isolated mitochondria and cultured cells. In addition, the company is developing innovative compounds targeting mitochondria to induce cell death specifically in cancer cells.
102 Av Gaston Roussel, 93230 Romainville
Targeted indications : breast cancer, lung cancer, colorectal cancer, prostate cancer, stomach cancer, supportive care, liver cancer, brain cancer, head & neck cancer, gastrointestinal cancer, gynecological cancer, bone cancer, genitourinary cancer, skin cancer, hematologic cancer, lymphoma, myeloma, leukemia, predictive toxicology.